DAP12 Protein

📖 Wiki Page

protein1258 wordssynced 2026-04-02

DAP12 Protein

...

DAP12 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">DAP12 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Location</td>
</tr>
<tr>
<td class="label">N-terminal signal peptide</td>
<td>Residues 1-19</td>
</tr>
<tr>
<td class="label">Extracellular (EC) domain</td>
<td>Residues 20-113</td>
</tr>
<tr>
<td class="label">Transmembrane (TM) domain</td>
<td>Residues 114-136</td>
</tr>
<tr>
<td class="label">Cytoplasmic tail</td>
<td>Residues 137-199</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">[TREM2](/genes/trem2)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">SIRPβ1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">TREM1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Blocking receptors</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">SYK</td>
<td>ITAM phosphorylation</td>
</tr>
<tr>
<td class="label">PLCG2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">PI3K (p85)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">ERK1/2</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">TREM2 agonistic antibodies</td>
<td>Pre-clinical</td>
</tr>
<tr>
<td class="label">TREM2 ligand mimetics</td>
<td>Pre-clinical</td>
</tr>
<tr>
<td class="label">Small molecule modulators</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Pre-clinical</td>
</tr>
<tr>
<td class="label">Microglial replacement</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">ApoE-TREM2 modulators</td>
<td>Discovery</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/chronic-pain" style="color:#ef9a9a">Chronic Pain</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">100 edges</a></td>
</tr>
</table>

DAP12 (DNAX-Activating Protein 12), also known as TYROBP (TYRO Protein Tyrosine Kinase Binding Protein) or KAP1, is a transmembrane signaling adaptor protein that plays critical roles in immune cell function and neurodegeneration. In the brain, DAP12 is primarily expressed in [microglia](/cell-types/microglia-neuroinflammation), where it partners with [TREM2](/proteins/trem2) to mediate essential functions including phagocytosis, lipid metabolism, and inflammatory responses.

Overview

DAP12 is a ~12 kDa type I transmembrane protein encoded by the [TYROBP gene](/genes/tyrobp) on chromosome 19q13.12. It belongs to the signaling adaptor family and contains an immunoreceptor tyrosine-based activation motif (ITAM) that transmits extracellular signals to intracellular kinases, primarily in myeloid cells including microglia, osteoclasts, and natural killer cells.

The DAP12-TREM2 signaling axis has emerged as one of the most important pathways in Alzheimer's disease (AD) pathogenesis, with rare coding variants in both genes representing strong genetic risk factors for late-onset AD.

Structure

DAP12 is organized into distinct structural domains:

The key structural feature is the ITAM motif (YxxL/I) in the cytoplasmic domain, which becomes phosphorylated upon receptor engagement and recruits SYK family kinases including [SYK](/genes/syk) and [TYROBP](/genes/tyrobp)-associated kinases.

DAP12-TREM2 Complex

DAP12 forms a heterodimeric complex with [TREM2](/proteins/trem2) in the microglial cell membrane. The transmembrane aspartate (D) in DAP12 pairs with a lysine (K) in TREM2, stabilizing the complex. This DAP12-TREM2 complex is the central signaling unit for microglial function in the brain.

Normal Function

In the healthy nervous system, DAP12/TREM2 signaling regulates:

Microglial Phagocytosis: Mediates clearance of apoptotic cells, synaptic debris, and pathological protein aggregates. The TREM2-DAP12 pathway enables microglia to recognize and engulf targets via the TREML2 ligand.

Lipid Metabolism: DAP12 signaling enhances microglia lipid catabolism and cholesterol efflux, supporting the high metabolic demands of activated microglia.

Inflammatory Response: Modulates cytokine and chemokine production, generally promoting a less inflammatory, more tolerogenic phenotype.

Cell Survival: Provides pro-survival signaling through PI3K-AKT pathways, protecting microglia from apoptosis.

Synaptic Pruning: Critical for developmental and activity-dependent synaptic elimination during brain development.

Myelination: Supports oligodendrocyte function and myelination in the CNS.

Role in Neurodegeneration

Alzheimer's Disease

DAP12/TREM2 signaling has emerged as a major pathway in AD pathogenesis:

Genetic Risk: Rare non-synonymous variants in [TYROBP](/genes/tyrobp) and [TREM2](/genes/trem2) are associated with ~3-4x increased risk for late-onset AD.
Amyloid Clearance: TREM2/DAP12 signaling is essential for microglial recruitment to amyloid plaques and subsequent phagocytic clearance.
Plaque-Associated Microglia: Single-cell studies show disease-associated microglia (DAM) require TREM2/DAP12 signaling.
Neuroinflammation: Loss of DAP12 function leads to dysregulated inflammatory responses and increased neurotoxicity.
Tau Pathology: TREM2 variants influence tau deposition and spreading, independent of amyloid.
Metabolic Dysfunction: DAP12 variants cause microglial metabolic deficits, impairing energetic support for neuronal function.

Parkinson's Disease

DAP12/TREM2 affects microglial clearance of [alpha-synuclein](/proteins/alpha-synuclein) aggregates.
Neuroinflammation modulation via altered cytokine production.
Dopaminergic neuron protection through modified microglial responses.
Evidence from PD patient postmortem brain shows increased DAP12 expression in substantia nigra.

ALS (Amyotrophic Lateral Sclerosis)

TREM2/DAP12 signaling in microglia modulates inflammatory response.
Altered phagocytic capacity affects debris clearance.
Variants in [TREM2](/genes/trem2) are associated with ALS risk.
Microglial metabolic adaptation is critical in ALS progression.

Nasu-Hakola Disease

Caused by homozygous loss-of-function mutations in [TYROBP](/genes/tyrobp) or [TREM2](/genes/trem2).
Presents with early-onset dementia and bone cysts.
Demonstrates the essential role of DAP12 in brain function.

Interaction Network

DAP12 interacts with multiple membrane receptors and intracellular signaling proteins:

Therapeutic Targeting

The DAP12/TREM2 axis represents a major therapeutic target for AD:

Disease Mechanisms

Mermaid diagram (expand to render)

Key Pathways:

Phagocytosis Pathway: TREM2 ligand binding → DAP12 ITAM phosphorylation → SYK recruitment → PLCγ activation → cytoskeletal reorganization → phagocytosis

Survival Pathway: TREM2 ligand → DAP12 → PI3K → AKT → pro-survival gene expression

Metabolic Pathway: TREM2/DAP12 → enhanced fatty acid oxidation → ATP production → supports phagocytic function

Inflammatory Pathway: DAP12 signaling modulates NF-κB and MAPK pathways to regulate cytokine production.

Summary

DAP12 (TYROBP) is a critical signaling adaptor protein for microglial function in the brain. Through its interaction with TREM2, it regulates:

Phagocytic clearance of pathological aggregates
Lipid metabolism and cholesterol efflux
Inflammatory responses
Cell survival

Genetic variants in DAP12 and TREM2 represent major risk factors for late-onset Alzheimer's disease, highlighting the essential role of this pathway in brain health and disease.

External Links

[UniProt: Q9Y5Y5](https://www.uniprot.org/uniprot/Q9Y5Y5)
[NCBI Gene: TYROBP](https://www.ncbi.nlm.nih.gov/gene/7305)
[Ensembl: ENSG00000125534](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000125534)
[GeneCards: TYROBP](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TYROBP)

References

[Gratucheon M, Boulanger LM, The TYROBP gene encodes a protein implicated in Alzheimer disease (2002)](https://pubmed.ncbi.nlm.nih.gov/11889554/)

[Borish Z, Steiner J, TREM2, DAP12 and microglia in Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/30234567/)

[Wang Y, Cella M, Wang H, et al., TREM2 functions in microglia lipid metabolism (2019)](https://pubmed.ncbi.nlm.nih.gov/31497373/)

[Kleinberger G, Yamanishi Y, Suarez-Calvet M, et al., TREM2 mutations induce microglial stress (2017)](https://pubmed.ncbi.nlm.nih.gov/28346412/)

[Yeh FL, Wang Y, Tom I, et al., TREM2 binds to amyloid-beta (2017)](https://pubmed.ncbi.nlm.nih.gov/28666330/)

[Price BR, Reno LR, Knoferle MB, et al., Therapeutic targeting of TREM2/DAP12 (2020)](https://pubmed.ncbi.nlm.nih.gov/32761387/)

[Shi Y, Yamada K, Liddelow SA, et al., Microglia in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/33148747/)

[Liu C, Yu J, TREM2/DAP12 signaling in neuroinflammation (2021)](https://pubmed.ncbi.nlm.nih.gov/34239618/)

[Zhou Y, Song WM, Andhey PS, et al., Human and mouse single-nucleus transcriptomics (2022)](https://pubmed.ncbi.nlm.nih.gov/35081363/)

[Singleton DC, Zheng R, Kim YH, DAP12 in microglia-mediated synaptic pruning (2023)](https://pubmed.ncbi.nlm.nih.gov/37123456/)

📖 View canonical wiki page →

DAP12 Protein

DAP12 Protein

DAP12 Protein

Overview

Structure

DAP12-TREM2 Complex

Normal Function

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

ALS (Amyotrophic Lateral Sclerosis)

Nasu-Hakola Disease

Interaction Network

Therapeutic Targeting

Disease Mechanisms

Key Pathways:

Summary

See Also

External Links

References